Epsilon M&A Deal Report - Novescia
Transaction Multiples for the Valuation of Private Companies
Cerba European Lab / Novescia
No EMAT :
69508
Announced Date :
16/01/2015
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Cerba European Lab
Target :
Novescia
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Founded by the end of 2007 by Ekkio Capital and Sylvain Chapuis , Novescia is a clinical laboratory testing group providing biological analysis services. > Specialises in two types of medical...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 27/05/2014 | Novacyt | Lab21 | England | ** | 68924 |
| 30/07/2012 | Fund raising led by Azulis Capital and Galia Gestion | SELAS Bio-Clinic | France | * | 68832 |
Source: Epsilon Research / EMAT
